Revenue (Quarterly) Chart

View Revenue (Quarterly) for KAOCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 2.879B
March 31, 2026 2.634B
December 31, 2025 2.964B
September 30, 2025 2.869B
June 30, 2025 2.899B
March 31, 2025 2.558B
December 31, 2024 2.877B
September 30, 2024 2.694B
June 30, 2024 2.709B
March 31, 2024 2.464B
December 31, 2023 2.750B
September 30, 2023 2.680B
June 30, 2023 2.841B
March 31, 2023 2.627B
December 31, 2022 2.994B
September 30, 2022 2.847B
June 30, 2022 2.981B
March 31, 2022 2.982B
December 31, 2021 3.498B
September 30, 2021 3.141B
June 30, 2021 3.242B
March 31, 2021 3.021B
December 31, 2020 3.606B
September 30, 2020 3.185B
June 30, 2020 3.063B
Date Value
March 31, 2020 3.099B
December 31, 2019 3.614B
September 30, 2019 3.614B
June 30, 2019 3.407B
March 31, 2019 3.149B
December 31, 2018 3.637B
September 30, 2018 3.308B
June 30, 2018 3.466B
March 31, 2018 3.238B
December 31, 2017 3.624B
September 30, 2017 3.271B
June 30, 2017 3.348B
March 31, 2017 3.040B
December 31, 2016 3.676B
September 30, 2016 3.474B
June 30, 2016 3.377B
March 31, 2016 2.910B
December 31, 2015 3.376B
September 30, 2015 3.012B
June 30, 2015 3.024B
March 31, 2015 2.765B
December 31, 2014 3.447B
September 30, 2014 3.283B
June 30, 2014 3.181B
March 31, 2014 3.320B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Kosé Holdings Corp. 543.76M
euglena Co., Ltd. 83.52M
Milbon Co., Ltd. 90.76M
Rohto Pharmaceutical Co., Ltd. 574.97M
Mandom Corp. 116.45M